One of the world’s leading vascular care manufacturers selects clinivation WorldView® as their enterprise solution for on-demand global regulatory intelligence.
Natick, MA, September 22, 2008 – clinivation, Inc. announced today that Abbott Vascular, a division of Abbott, has selected the clinivation WorldView® enterprise solution for On-Demand Global Regulatory Intelligence.
“Abbott Vascular is clearly an innovative global leader in vascular care, and we are pleased that they have chosen clinivation WorldView® for comprehensive, authoritative, and up-to-date global regulatory intelligence,” said Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions.
About clinivation WorldView® On-Demand Global Regulatory Intelligence
Clinivation WorldView® is the medical device and diagnostic industry’s most comprehensive, authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory Intelligence. Providing clear, step-by-step market clearance regulations, processes, and guidance for >99% of the world markets, only clinivation WorldView® delivers tried-and-true intelligence from certified, practicing professionals with real-world experience.
About Abbott Vascular International
Headquartered in Northern California, Abbott Vascular, a division of Abbott, is one of the world’s leading vascular care businesses. Abbott Vascular is uniquely focused on transforming the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development, and advancing medicine through training and education.
Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular, and coronary products, which are recognized internationally for their safety, effectiveness, and ease of use in treating patients with vascular disease.
For more information, please visit www.abbottvascular.com.
Abbott is a global, broad-based health care company with sales, manufacturing, research and development, and distribution facilities around the world. Abbott is devoted to discovering new medicines, new technologies, and new ways to manage health, and its products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott’s areas of expertise include anesthesia, animal health, anti-infectives, cardiovascular care, diabetes care, hematology, immunodiagnostics and clinical chemistry, immunology, metabolics, neuroscience, nutrition, oncology, pain care, point of care, renal care, vascular care, and virology.
Throughout its 120+ year history, Abbott has been driven by the goal of advancing medical science to help people live healthier lives.
For more information, please visit www.abbott.com.